Clinical trials recruiting for Lupus Erythematosus, Systemic
20
Recruiting trials
24
US states with sites
38
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 4 |
| Illinois | 4 |
| North Carolina | 4 |
| Florida | 3 |
| Massachusetts | 3 |
| Michigan | 3 |
| Missouri | 3 |
| Texas | 3 |
| Georgia | 2 |
| Iowa | 2 |
| Louisiana | 2 |
| New York | 2 |
Top cities
Boston, Massachusetts 3Chicago, Illinois 3St Louis, Missouri 3Chapel Hill, North Carolina 2Charlotte, North Carolina 2Houston, Texas 2Iowa City, Iowa 2Miami, Florida 2Miami Lakes, Florida 2Portland, Oregon 2
Self-screener
Recruiting trials
- A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
- Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
- Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases
- Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- Chinese Rheumatism Biobank(CRB)
- Dose Response of Exercise for Arthritis Management
- Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus
- Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
- Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
- Meir Medical Center Rheumatologic Biobank
- NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
- To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
- Trial of Belimumab in Early Lupus
- Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus
Related conditions
Trials recruiting for Lupus Erythematosus, Systemic often also study these conditions. Each links to its own recruiting-trial list.
Lupus 332Rheumatoid arthritis 314Systemic Sclerosis 27Sjogren's Syndrome 25Lupus Nephritis 49Fibromyalgia 142Systemic Sclerosis (SSc) 28SLE (Systemic Lupus) 7Sjogren Syndrome 8Psoriasis 233
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lupus Erythematosus, Systemic trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.